Michel Drancourt
2
Documents
Identifiants chercheurs
michel-drancourt- IdRef : 060258411
-
0000-0003-0768-1139
- VIAF : 172769318
Présentation
Publications
- 1
- 1
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, FranceEuropean Journal of Clinical Microbiology and Infectious Diseases, 2021, 40 (2), pp.361-371. ⟨10.1007/s10096-020-04104-2⟩
Article dans une revue
hal-03149250v1
|
|
|
|
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysisTravel Medicine and Infectious Disease, 2020, 36, pp.101791. ⟨10.1016/j.tmaid.2020.101791⟩
Article dans une revue
hal-03138793v1
|